A concise synthesis of (±) and a total synthesis of (+)-epiquinamide
摘要:
A total synthesis of the quinolizidine alkaloid (+)-epiquinamide 1 has been achieved starting from (-)-pipecolinic acid 3. The key step is the highly diastereoselective addition of a TBDMS-protected propargyl alcohol to a chiral aldehyde derived from 3 to give erythro alkynol 19, which is then easily transformed into the desired bicyclic skeleton. (c) 2006 Elsevier Ltd. All rights reserved.
A concise synthesis of (±) and a total synthesis of (+)-epiquinamide
摘要:
A total synthesis of the quinolizidine alkaloid (+)-epiquinamide 1 has been achieved starting from (-)-pipecolinic acid 3. The key step is the highly diastereoselective addition of a TBDMS-protected propargyl alcohol to a chiral aldehyde derived from 3 to give erythro alkynol 19, which is then easily transformed into the desired bicyclic skeleton. (c) 2006 Elsevier Ltd. All rights reserved.
An approach towards the total synthesis of (+)-epiquinamide and (+)-α-conhydrine from Garner aldehyde
作者:Ajay Kumar Srivastava、Sanjit Kumar Das、Gautam Panda
DOI:10.1016/j.tet.2009.04.074
日期:2009.7
A short and stereoselectiveroute for the synthesis of 1-hydroxyquinolizidine, an advanced synthetic intermediate for the total synthesis of (+)-epiquinamide is presented. The key synthetic steps involve diastereoselective nucleophilic addition on l-serine derived Garner aldehyde and acid mediated (PTSA) ring closing metathesis. The methodology is also elaborated successfully for the total synthesis
A concise synthesis of (±) and a total synthesis of (+)-epiquinamide
作者:Sok Teng (Amy) Tong、David Barker
DOI:10.1016/j.tetlet.2006.05.092
日期:2006.7
A total synthesis of the quinolizidine alkaloid (+)-epiquinamide 1 has been achieved starting from (-)-pipecolinic acid 3. The key step is the highly diastereoselective addition of a TBDMS-protected propargyl alcohol to a chiral aldehyde derived from 3 to give erythro alkynol 19, which is then easily transformed into the desired bicyclic skeleton. (c) 2006 Elsevier Ltd. All rights reserved.